Justin Schweitzer OD, FAAO
Dr. Justin Schweitzer is a fellowship-trained optometrist specializing in the treatment of glaucoma, corneal-related vision conditions, and cataracts at Vance Thompson Vision in Sioux Falls, SD.
7
Heru Wearable Visual Fields: Enhancing Patient Care
In this session from Eyes on Glaucoma 2022, Stephanie Woo, OD, FAAO, FSLS, and Justin Schweitzer, OD, FAAO, discuss how Heru’s wearable platform is redefining visual field testing.
Drops and Dry Eye: QOL Considerations for the Glaucoma Patient
Best practices for managing glaucoma with ocular surface disease take into account health-related quality of life considerations. In this lecture, Ahmad Fahmy, OD, and Justin Schweitzer, OD, address HRQOL and establishing an effective OSD treatment algorithm in these patients.
The 2022 Glaucoma Report
We surveyed over 750 eyecare professionals on their approaches to the diagnosis, treatment, and management of glaucoma. Download your free copy of the report to learn how your colleagues in optometry and ophthalmology are approaching this disease!
What Role Do ODs Play in Glaucoma Surgery?
Glaucoma is on the rise. With the “Don’t Wait For Too Late” campaign, Sight Sciences is advancing education on early intervention with MIGS while enhancing the collaborative environment between optometry and ophthalmology.
Eyes On 2022 Optometry On Demand
Missed Eyes On 2022? You can still catch some of the top sessions from the largest virtual event of the year for ECPs. From updates in presbyopia and orthokeratology to innovations in MIGS, this year’s event was packed with value-rich sessions. Access on-demand recordings from 11 sessions now.
The 2021 Glaucoma Report
We surveyed 667 optometrists on glaucoma diagnosis, treatment, and management. Download your free copy of the 2021 Glaucoma Report to see how your practice compares.
The OD's Guide to Sustained Release Glaucoma Treatments
Like many areas in glaucoma, drug delivery is evolving at a rapid pace, and optometry should be armed to collaborate in this care. This review covers currently available options and previews future sustained-release glaucoma treatments.